Page 161 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 161

146   SECTION I  General Pathology

                     Q. Define and classify paraneoplastic syndromes.

                     Ans. A paraneoplastic syndrome is a symptom complex in patients with cancer that cannot 
                     be explained either by local or distant spread of the tumour or by the elaboration of hor-
                     mones indigenous to the tissue of origin of the tumour.
                     Salient Features and Classification of Paraneoplastic Syndromes
                     •  Paraneoplastic syndromes are seen in 10–15% patients with cancer and are important 
                       to recognize because:
                       •  They may be the earliest manifestation of occult or hidden cancer in some cases.
                       •  They may manifest with signs and symptoms due to excessive production of that hormone.
                       •  They may mimic metastatic disease.
                     •  Paraneoplastic syndromes can be classified into:
                       •  Endocrinopathies
                       •  Nerve and muscle syndrome
                       •  Dermatological disorders
                       •  Vascular and haematological changes
                       •  Bone and soft-tissue changes
                     Endocrinopathies
                     These are characterized by production of ectopic hormones or hormone-like substances 
                     by cells of nonendocrine origin, eg, Cushing syndrome caused by ACTH or ACTH-like 
                     substances produced by small cell carcinoma of lung, pancreatic carcinoma or neural tu-
                     mours;  hypercalcemia  (most  common  paraneoplastic  syndrome)  caused  by  excess 
                     parathormone or related hormones (TNF-alfa, TGF-beta and IL-1) secreted by squamous 
                     cell  carcinoma  of  lung,  carcinomas  of  breast,  kidney,  ovary  and  ATLL;  and  Carcinoid
                     syndrome produced by elaboration of serotonin and bradykinin by bronchial adenomas, 
                     pancreatic carcinomas and gastric carcinomas.
                     Nerve and Muscle Syndrome
                     Examples include immunologically mediated myasthenia gravis in bronchogenic carcinoma, 
                     and disorders of the central and peripheral nervous system seen in breast carcinoma.

                     Dermatological Disorders
                     Acanthosis nigricans may be a manifestation of carcinoma of the lung, uterus or stomach. 
                     Dermatomyositis may be seen in bronchogenic and breast carcinoma.

                     Vascular and Haematological Changes
                     Tumour products (usually mucins that activate clotting factors) of pancreatic and broncho-
                     genic carcinoma can induce venous thrombosis (Trousseau sign). Nonbacterial throm-
                     botic  endocarditis  (due  to  hypercoagulability)  is  seen  in  many  advanced  cancers;  and 
                     anaemia may develop in association with thymic neoplasms (cause is unknown).


                     Bone and Soft-Tissue Changes
                     Hypertrophic osteoarthropathy and clubbing are common presenting symptoms of bron-
                     chogenic carcinoma (cause is unknown).

                     Q. Write briefly on laboratory diagnosis of cancer.
                     Ans. The modalities for laboratory diagnosis of cancer include:
                       1.  Cytology
                        The main techniques used for cytological diagnosis are:
                                                               Direct
                        (a) Fine needle aspiration cytology (FNAC)
                                                                Image guided




                                  mebooksfree.com
   156   157   158   159   160   161   162   163   164   165   166